Net Income

Bolstered by a massive capital infusion and strong investor demand, Vaxcyte is set to accelerate its broad-spectrum vaccine pipeline against market leaders.

Oregon's Summit Bank announces a new share repurchase, a move analysts see as a sign of robust financial health and a commitment to shareholder value.

Swedish hygiene giant Essity finalizes its acquisition of major feminine care brands, aiming to challenge market leaders in North America.

With the FIFA World Cup and America250 looming, Amtrak is bracing for record crowds. Is the system ready for its biggest test in 55 years?

Once valued at $3.3B, the healthtech giant seeks Chapter 11 protection, a stark warning for the post-pandemic digital health industry.

The tire retailer returns to the prestigious list, highlighting how its people-first strategy is a winning formula in a challenging retail market.

The American Water Charitable Foundation launches its 2026 grant program, funding vital community projects for clean water, conservation, and education.

With dentist burnout at crisis levels, one veteran practitioner offers a $6M blueprint to help owners escape the grind and reclaim their lives.

A new giant enters the ring. Akralos Animal Nutrition, an ADM-Alltech venture, launches with 40+ mills, aiming to reshape the North American market.

Kong Inc. unveils a new architectural vision to unify APIs, models, and agents, aiming to solve the enterprise challenge of scaling AI safely and efficiently.

Beyond M&A, ACROBiosystems' bioSeedin summit redefines growth, connecting global capital with biotech innovation in a new era of strategic partnerships.

As AI systems deny healthcare claims at alarming rates, experts argue that human oversight is the only safeguard for both patients and payors.

Japanese insurer Meiji Yasuda finalizes its acquisition of a top U.S. life and pension player, signaling a major strategic push into the American market.

Devonian appoints veteran CFO Dennis Turpin and corrects stock options, signaling a strategic shift as it aims to overcome financial hurdles and advance its pipeline.

With home health aide costs nearing $78,000 annually, families face a financial maze. Learn key strategies for creating a realistic budget for senior care.

A new campaign from ZOLL LifeVest and the AHA targets the deadly disparity in women's cardiac care, blending advocacy with life-saving wearable technology.

AI identity firm Trust Stamp unveils a bold 2026 plan, targeting acquisitions, African markets, and the stablecoin economy to fuel its global expansion.

Ensem Therapeutics expands its global trial for ETX-636, a next-gen cancer drug designed to avoid common toxicities, into China's vast patient market.

With a major Phase 3 trial now in Europe, Crystalys Therapeutics aims to fill a critical gap in gout care with a drug already proven in Asian markets.

Shanghai's AI EdTech innovator Jinxin faces a potential Nasdaq delisting after its stock plummets, putting its high-tech vision against market reality.